Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,422 | 87,978 | 35,114 | 26,389 | 12,232 |
| Receivables | 5,159 | 5,797 | 3,890 | 5,396 | 4,467 |
| Inventories | 2,674 | 2,025 | 1,987 | 1,967 | 2,114 |
| TOTAL | $82,453 | $96,803 | $41,948 | $37,529 | $20,902 |
| Non-Current Assets | |||||
| PPE Net | 2,120 | 2,078 | 1,952 | 1,994 | 1,925 |
| Other Non-Current Assets | 5,377 | 5,402 | 5,359 | 4,703 | 4,556 |
| TOTAL | $7,497 | $7,479 | $7,311 | $6,697 | $6,481 |
| Total Assets | $89,951 | $104,282 | $49,259 | $44,227 | $27,383 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 9,167 | 6,667 | 4,167 | 1,667 |
| Accounts payable and accrued liabilities | 1,835 | 2,386 | 2,727 | 1,770 | 2,039 |
| Accrued Expenses | 7,871 | 5,371 | 5,853 | 5,084 | 5,802 |
| TOTAL | $10,153 | $17,356 | $15,664 | $11,464 | $9,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,993 | 8,457 | 10,921 | 13,386 |
| Other Non-Current Liabilities | 582 | 700 | 815 | 527 | 643 |
| TOTAL | $582 | $6,693 | $9,272 | $11,449 | $14,028 |
| Total Liabilities | $10,735 | $24,049 | $24,936 | $22,913 | $23,965 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,264 | 43,176 | 43,158 | 36,231 | 35,051 |
| Common Shares | 43 | 43 | 37 | 36 | 33 |
| Retained earnings | -196,627 | -195,949 | -195,109 | -192,242 | -188,790 |
| Other shareholders' equity | -1,734 | -517 | 531 | 1,136 | 526 |
| TOTAL | $79,216 | $80,233 | $24,323 | $21,314 | $3,418 |
| Total Liabilities And Equity | $89,951 | $104,282 | $49,259 | $44,227 | $27,383 |